anmelden
BX Swiss TOP 30 CHF
1.428,93
PKT
+17,88
PKT
+1,27
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.09.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.09.18 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 19.09.18 | Roche Neutral | UBS AG | |
| 19.09.18 | Nestlé Underperform | Credit Suisse Group | |
| 18.09.18 | UBS buy | Deutsche Bank AG | |
| 18.09.18 | UBS Hold | Deutsche Bank AG | |
| 14.09.18 | Roche Neutral | UBS AG | |
| 14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.09.18 | ABB (Asea Brown Boveri) buy | Société Générale Group S.A. (SG) | |
| 12.09.18 | Swiss Re Sell | UBS AG | |
| 12.09.18 | UBS buy | Goldman Sachs Group Inc. | |
| 12.09.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 11.09.18 | Novartis buy | Citigroup Corp. | |
| 11.09.18 | Novartis Neutral | UBS AG | |
| 11.09.18 | Roche Underperform | BNP PARIBAS | |
| 11.09.18 | Novartis Neutral | BNP PARIBAS | |
| 10.09.18 | UBS buy | Société Générale Group S.A. (SG) | |
| 10.09.18 | UBS buy | Société Générale Group S.A. (SG) | |
| 10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 10.09.18 | UBS overweight | JP Morgan Chase & Co. | |
| 10.09.18 | UBS overweight | JP Morgan Chase & Co. | |
| 10.09.18 | Holcim Hold | Deutsche Bank AG | |
| 10.09.18 | UBS Equal weight | Barclays Capital | |
| 07.09.18 | Swiss Re overweight | Barclays Capital | |
| 07.09.18 | Zurich Insurance Equal weight | Barclays Capital | |
| 07.09.18 | Novartis buy | Jefferies & Company Inc. | |
| 07.09.18 | Roche buy | Jefferies & Company Inc. | |
| 07.09.18 | Roche overweight | JP Morgan Chase & Co. | |
| 07.09.18 | UBS Outperform | RBC Capital Markets | |
| 07.09.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 06.09.18 | Novartis buy | Kepler Cheuvreux | |
| 06.09.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 06.09.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 06.09.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 05.09.18 | Holcim kaufen | Bernstein Research | |
| 04.09.18 | UBS overweight | JP Morgan Chase & Co. | |
| 04.09.18 | UBS overweight | JP Morgan Chase & Co. | |
| 04.09.18 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 04.09.18 | Nestlé Equal weight | Barclays Capital |